Some pathogens have developed mechanisms to evade the inhibitory effects of antibiotics targeting folate biosynthesis. For instance, mutations in the genes encoding the enzymes of the folate pathway can reduce drug binding affinity. Additionally, some bacteria can acquire resistance genes through horizontal gene transfer, enabling them to bypass the inhibited steps of the pathway.
